CN109789110A - 包含羟基酪醇和乳香酸的组合物 - Google Patents

包含羟基酪醇和乳香酸的组合物 Download PDF

Info

Publication number
CN109789110A
CN109789110A CN201780061735.7A CN201780061735A CN109789110A CN 109789110 A CN109789110 A CN 109789110A CN 201780061735 A CN201780061735 A CN 201780061735A CN 109789110 A CN109789110 A CN 109789110A
Authority
CN
China
Prior art keywords
composition
hydroxytyrosol
subject
beta
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780061735.7A
Other languages
English (en)
Chinese (zh)
Inventor
泰德·亨德森
大卫·格里芬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Priority to CN202510507272.9A priority Critical patent/CN120241745A/zh
Publication of CN109789110A publication Critical patent/CN109789110A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201780061735.7A 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物 Pending CN109789110A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202510507272.9A CN120241745A (zh) 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662403807P 2016-10-04 2016-10-04
US62/403,807 2016-10-04
PCT/US2017/028857 WO2018067200A1 (en) 2016-10-04 2017-04-21 Compositions comprising hydroxytyrosol and boswellic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202510507272.9A Division CN120241745A (zh) 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物

Publications (1)

Publication Number Publication Date
CN109789110A true CN109789110A (zh) 2019-05-21

Family

ID=58664857

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201780061735.7A Pending CN109789110A (zh) 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物
CN202510507272.9A Pending CN120241745A (zh) 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202510507272.9A Pending CN120241745A (zh) 2016-10-04 2017-04-21 包含羟基酪醇和乳香酸的组合物

Country Status (9)

Country Link
US (3) US11241444B2 (https=)
EP (2) EP4623994A3 (https=)
JP (4) JP7079551B2 (https=)
CN (2) CN109789110A (https=)
AU (3) AU2017340126B2 (https=)
CA (1) CA3039233A1 (https=)
ES (1) ES3040765T3 (https=)
PL (1) PL3522874T3 (https=)
WO (1) WO2018067200A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7079551B2 (ja) 2016-10-04 2022-06-02 ニュートラマックス ラボラトリーズ，インコーポレイテッド ヒドロキシチロソールおよびボスウェリン酸を有する組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101516364A (zh) * 2006-07-14 2009-08-26 帝斯曼知识产权资产管理有限公司 组合物及其用于治疗、共治疗或预防炎性病症的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358542B2 (en) 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
US7713569B2 (en) 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
JP3820218B2 (ja) 2000-09-01 2006-09-13 クレアグリ， インコーポレイテッド 植物水からヒドロキシチロソール富化組成物を得る方法
CA2474798C (en) 2002-02-13 2012-12-04 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
US20030199581A1 (en) 2002-03-13 2003-10-23 Seligson Allen L. Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses
EP1582512A1 (en) 2004-03-31 2005-10-05 Cognis IP Management GmbH Process for obtaining hydroxytyrosol from olive leaves extracts
US7625947B2 (en) 2004-06-18 2009-12-01 Laila Nutraceuticals Analogs of 3-O-acetyl-11-keto-β-boswellic acid
WO2006020588A1 (en) * 2004-08-09 2006-02-23 Creagri, Inc. Olive compositions and methods for treating inflammatory conditions
WO2008006582A1 (en) 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
JP2008120716A (ja) 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
KR101682512B1 (ko) * 2008-09-15 2016-12-05 라일라 뉴트라슈티칼스 보스웰리아 세라타 추출물을 포함하는 상승적인 항-염증 조성물
CN102451428A (zh) * 2010-10-14 2012-05-16 中国中医科学院广安门医院 可用于治疗类风湿关节炎的中药组合物
WO2014085613A1 (en) * 2012-11-30 2014-06-05 Mccord Darlene E Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
US10342802B2 (en) 2016-10-04 2019-07-09 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid
JP7079551B2 (ja) 2016-10-04 2022-06-02 ニュートラマックス ラボラトリーズ，インコーポレイテッド ヒドロキシチロソールおよびボスウェリン酸を有する組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101516364A (zh) * 2006-07-14 2009-08-26 帝斯曼知识产权资产管理有限公司 组合物及其用于治疗、共治疗或预防炎性病症的用途

Also Published As

Publication number Publication date
CA3039233A1 (en) 2018-04-12
EP3522874B1 (en) 2025-07-02
JP2024166415A (ja) 2024-11-28
JP2023159387A (ja) 2023-10-31
JP7562225B2 (ja) 2024-10-07
JP7341596B2 (ja) 2023-09-11
AU2023203427B2 (en) 2025-02-06
ES3040765T3 (en) 2025-11-04
US20220110946A1 (en) 2022-04-14
AU2017340126A1 (en) 2019-04-11
WO2018067200A1 (en) 2018-04-12
US11241444B2 (en) 2022-02-08
US11980624B2 (en) 2024-05-14
JP2022110125A (ja) 2022-07-28
AU2017340126B2 (en) 2023-03-02
JP2019529482A (ja) 2019-10-17
US20200222424A1 (en) 2020-07-16
CN120241745A (zh) 2025-07-04
JP7079551B2 (ja) 2022-06-02
AU2023203427A1 (en) 2023-06-29
EP4623994A3 (en) 2025-11-19
AU2025202875A1 (en) 2025-05-15
US20240285648A1 (en) 2024-08-29
EP3522874A1 (en) 2019-08-14
PL3522874T3 (pl) 2025-10-06
EP4623994A2 (en) 2025-10-01

Similar Documents

Publication Publication Date Title
CN109512816A (zh) 包含鳄梨/大豆不皂化物和类脂酸的口服施用组合物及施用方法
US20240285648A1 (en) Compositions comprising hydroxytyrosol and boswellic acid
US10722524B2 (en) Compositions comprising hydroxytyrosol and boswellic acid
CN115154465A (zh) 化合物治疗犬中退行性关节疾病的疼痛和炎症的用途
Carvalho et al. Repercussions of long‐term naproxen administration on LPS‐induced periodontitis in male mice
AU2015372438B2 (en) Formulation and method of use
Burns Mobility matters: Nutritional management of canine joint disease
Jarvis Clinical care of the geriatric horse
Farhan et al. Evaluation of the pharmacological effects of Serratiopeptidase on the central nervous system in mice
DK2538937T5 (en) The combination of a centrally acting analgesic, and a selective cyclooxygenase-2 inhibitor anti-inflammatory agent for treating inflammation and pain in the veterinary field
CN103599094A (zh) 4-氧代戊酸在制备止泻药物中用途
EA021199B1 (ru) Способ терапевтического или профилактического лечения невропатической боли, хронической боли и фибромиалгии
KR20130035425A (ko) Ｈｓ1792를 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 조성물
CN109876017A (zh) 用于提高人体免疫功能的新药生物反应调节剂
HK1236832A1 (en) Formulation, producing method and use thereof
HK1236832B (zh) 制剂及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190521